APA

Build Trust at Work: Join the UKG HR and Payroll eSymposium on June 12

Retrieved on: 
torsdag, maj 9, 2024

With trust acting as the new currency in today’s workplace, UKG is hosting a free, virtual UKG HR & Payroll eSymposium next month with sessions that will tackle the ROI of trust, the role of compliance and payroll, how to retain top employees, and the promising potential of generative AI (GenAI).

Key Points: 
  • With trust acting as the new currency in today’s workplace, UKG is hosting a free, virtual UKG HR & Payroll eSymposium next month with sessions that will tackle the ROI of trust, the role of compliance and payroll, how to retain top employees, and the promising potential of generative AI (GenAI).
  • View the full agenda and visit the speakers page to check out the full lineup of thought leaders.
  • June 12 at 10:00 a.m.
  • ET
    Register to attend the live virtual event.

Grant Thornton’s Steven Wrappe named a Bloomberg Tax Author Award recipient

Retrieved on: 
torsdag, maj 9, 2024

Steven Wrappe , managing director and transfer pricing technical leader in the firm’s Washington National Tax office, has been named the Federal Tax Contributing Author of the Year as part of the Bloomberg Tax Author Awards .

Key Points: 
  • Steven Wrappe , managing director and transfer pricing technical leader in the firm’s Washington National Tax office, has been named the Federal Tax Contributing Author of the Year as part of the Bloomberg Tax Author Awards .
  • This honor is the latest achievement for Wrappe, a tax leader and globally-recognized authority in transfer pricing.
  • Wrappe is well known for his ability to help large multinational clients in areas such as planning, compliance and dispute resolution.
  • “This award reaffirms my dedication to advancing our profession, and I will continue to contribute through outlets like Bloomberg Tax and empower others with valuable knowledge that makes a difference."

Identiv Reports First Quarter 2024 Financial Results

Retrieved on: 
onsdag, maj 8, 2024

Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), today released its financial results for the first quarter ended March 31, 2024.

Key Points: 
  • Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), today released its financial results for the first quarter ended March 31, 2024.
  • Revenue for the first quarter 2024 was $22.5 million, compared to $29.0 million in the prior quarter and $26.0 million in the first quarter of 2023.
  • Non-GAAP operating expenses were $10.4 million in the first quarter of 2024, compared to $9.8 million in the prior quarter and $10.6 million in the first quarter of 2023.
  • Identiv management will hold a conference call today, May 8, 2024, at 5:00 p.m. EDT (2:00 p.m. PDT) to discuss the company’s first quarter 2024 financial results.

Defined Sleep to Share Groundbreaking Research at the American Psychiatric Association 2024 Conference

Retrieved on: 
tisdag, maj 7, 2024

Defined Sleep, a pioneer in scientifically developed, supported, and validated CBD sleep supplements , is proud to announce its upcoming participation in the American Psychiatric Association (APA) 2024 Annual Meeting from May 4-8, 2024.

Key Points: 
  • Defined Sleep, a pioneer in scientifically developed, supported, and validated CBD sleep supplements , is proud to announce its upcoming participation in the American Psychiatric Association (APA) 2024 Annual Meeting from May 4-8, 2024.
  • At the conference, Defined Sleep will showcase its latest research findings at their exhibition booth on the critical link between sleep quality and mental health.
  • The Defined Sleep research team, led by Dr. Paul Muchowski, will highlight evidence-based strategies for enhancing sleep hygiene to improve overall mental well-being.
  • Expertise in Science: The founder of Defined Sleep will share information about practical sleep hygiene techniques for mental health professionals.

Otsuka America, Inc’s. Data and Technology Company will Support Rejoyn™ Commercialization & Personalized Patient Engagement

Retrieved on: 
måndag, maj 6, 2024

OPH will focus on the patient experience as a core piece of improving how better outcomes might be achieved across nephrology, mental health, and beyond.

Key Points: 
  • OPH will focus on the patient experience as a core piece of improving how better outcomes might be achieved across nephrology, mental health, and beyond.
  • OPH will serve to commercialize Rejoyn™.
  • Otsuka is deepening its commitment to the meaningful role technology can play in the lives of patients and the care teams that surround them.
  • “At this time there is a great desire for alternative therapies and treatments in the mental health space, especially given the outpaced demand in recent years,” said Shah.

Monique Honer Joins TTI Success Insights as Director of Learning & Certifications

Retrieved on: 
tisdag, maj 7, 2024

SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire-PRWeb/ -- TTI Success Insights, a global provider of research-backed assessments, has hired Monique Honer as Director of Learning & Certifications. Honer's work will be focused on creating and implementing transformational learning experiences designed to challenge individuals to master existing skills while continuously developing new proficiencies, knowledge, and behaviors.

Key Points: 
  • SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire-PRWeb/ -- TTI Success Insights, a global provider of research-backed assessments, has hired Monique Honer as Director of Learning & Certifications.
  • In her new role, Honer will lead the long-term company goals of optimizing learning, creating new certification programs, and moving the company toward empowered and adaptive learning.
  • TTI University features expanded offerings for TTI partners and organizations through live facilitation, eLearning, on-demand, micro-learning, business acumen, and more.
  • TTI Success Insights is an industry-leading, award-winning assessment provider based in Scottsdale, AZ that is dedicated to sparking transformative experiences through assessment solutions and research.

ECARX Releases Multiple Intelligent Driving Features for Skyland Pro

Retrieved on: 
fredag, maj 3, 2024

SHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today announced the launch of multiple intelligent driving and safety features for its Skyland Pro computing platform, which significantly enhance the intelligent driving experience.

Key Points: 
  • SHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today announced the launch of multiple intelligent driving and safety features for its Skyland Pro computing platform, which significantly enhance the intelligent driving experience.
  • The highway NOA feature will initially cover Zhejiang province, Jiangsu province, Guangdong province, and Shanghai in China, with a nationwide rollout soon to follow.
  • “The initial launch of these intelligent driving and safety features for the Skyland Pro platform on the Lynk & Co. 08 EM-P reflects the significant progress we are making to consistently improve the intelligent driving experience,” commented ECARX Chairman and CEO Ziyu Shen.
  • “Together with our ecosystem of partners, we are driving technical innovation across the industry.

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

Retrieved on: 
lördag, maj 4, 2024

MM120 demonstrated clinically and statistically significant efficacy compared to placebo at its primary week 4 and secondary week 12 timepoints.

Key Points: 
  • MM120 demonstrated clinically and statistically significant efficacy compared to placebo at its primary week 4 and secondary week 12 timepoints.
  • The study was presented at the APA Annual Meeting, the largest psychiatry-focused scientific meeting in the world, in New York City being held May 4 – 8, 2024.
  • MM120 was administered as a single dose in a monitored clinical setting, with no additional therapeutic intervention, to demonstrate the medication’s effect.
  • In today’s presentation of the Phase 2b study with MM120, investigators presented results from the assessment of several additional secondary endpoints that were pre-specified.

Falcon Oil & Gas Ltd - Binding Term Sheet for Gas Sales Agreement to supply pilot gas to the Northern Territory Government

Retrieved on: 
tisdag, april 23, 2024

Falcon Oil & Gas Ltd.

Key Points: 
  • Falcon Oil & Gas Ltd.
    23 April 2024 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that the Beetaloo Joint venture (BJV) has signed a Binding Agreement for a long-term Gas Sales Agreement (GSA) to supply the Northern Territory Government (Buyer) with 14.6 PJ (13.8 BCF) per annum from the proposed Shenandoah South Pilot Project for an initial term of nine years, with a Buyer’s option to extend for a further six-and-a-half years.
  • Details of the Binding Agreement are as follows:
    Gas will be delivered to the APA-owned Amadeus Gas Pipeline (AGP) on a take-or-pay basis at a market-competitive gas price, escalating at 100% of the Consumer Price Index (CPI).
  • The Buyer’s extension option is at a slightly discounted price.
  • Falcon Oil & Gas Australia Limited holds a 5% working interest in the 51,200-acre area that will include the wells required to deliver the proposed Pilot Project volumes.

Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

Retrieved on: 
torsdag, maj 2, 2024

Today, Osmind , the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry.

Key Points: 
  • Today, Osmind , the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry.
  • This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine.
  • PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community.
  • Through this collaboration, Osmind is enabling independent practices to contribute to the evolution of the field and elevate their own evidence-based practices.